Literature DB >> 8801208

Influence of dietary nucleotides on liver structural recovery and hepatocyte binuclearity in cirrhosis induced by thioacetamide.

M I Torres-López1, I Fernandez, L Fontana, A Gil, A Rios.   

Abstract

Intake of thioacetamide in drinking water causes liver cirrhosis in rats, which exhibit many changes similar to human disease. Nucleotides play an important part in major cellular functions, and recent studies suggest that dietary nucleotides may be considered 'semi-essential' nutrients in situations when an inadequate dietary supply may affect the growth of tissues with a rapid turnover rate. The aim of this study was to assess the effect of dietary nucleotides on lesions in thioacetamide-cirrhotic rats, and to calculate the proportion of mono and binucleated hepatocytes in different experimental groups. Rats were given cirrhosis by oral intake of thioacetamide in the drinking water (300 mg/l) for four months. One group was treated with a standard nucleotide free diet, and another group was treated with the same diet supplemented with 250 mg of nucleotides per 100 g of diet for one and two weeks. A striking reduction (mean (SEM)) in the proportion of binucleated cells was seen in thioacetamide-cirrhotic rats (4.8 (1.3) v 21.4 (1.0)), showing a change in the mitotic mechanism in focal lesions. Cirrhotic rats that consumed a semipurified diet supplemented with nucleotides during two weeks showed considerable histological regeneration of the injured liver. These animals had significantly higher proportion of binucleated cells than did animals at the beginning of the recovery period (8.2 (1.2) v 4.8 (1.3)). In the second week of recovery, both types of diet (F = 5.54, p < 0.05) and the previous administration of thioacetamide (F = 142.82, p < 0.001) had significant effects on the percentage of binucleated hepatocytes.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8801208      PMCID: PMC1383034          DOI: 10.1136/gut.38.2.260

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  20 in total

1.  Production of cancer of the bile ducts with thioacetamide.

Authors:  D N GUPTA
Journal:  Nature       Date:  1955-02-05       Impact factor: 49.962

Review 2.  Nutritional support in liver failure.

Authors:  R Latifi; R W Killam; S J Dudrick
Journal:  Surg Clin North Am       Date:  1991-06       Impact factor: 2.741

3.  The connection between the nuclei of binucleated hepatocytes: an ultrastructural study.

Authors:  K Kachi; S W French
Journal:  J Submicrosc Cytol Pathol       Date:  1994-04

4.  Biochemical and morphological studies on production and regression of experimental liver cirrhosis induced by thioacetamide in Uje: WIST rats.

Authors:  T Zimmermann; A Müller; G Machnik; H Franke; H Schubert; R Dargel
Journal:  Z Versuchstierkd       Date:  1987

5.  Problems with animal models of chronic liver disease: suggestions for improvement in standardization.

Authors:  K D Mullen; A J McCullough
Journal:  Hepatology       Date:  1989-03       Impact factor: 17.425

Review 6.  Liver regeneration: molecular mechanisms of growth control.

Authors:  G K Michalopoulos
Journal:  FASEB J       Date:  1990-02-01       Impact factor: 5.191

7.  Thioacetamide hepatocarcinogenesis.

Authors:  F F Becker
Journal:  J Natl Cancer Inst       Date:  1983-09       Impact factor: 13.506

8.  Relationship between genomic DNA ploidy and parameters of liver damage during necrosis and regeneration induced by thioacetamide.

Authors:  C Díez-Fernández; L Boscá; L Fernández-Simón; A Alvarez; M Cascales
Journal:  Hepatology       Date:  1993-10       Impact factor: 17.425

9.  Effects of total parenteral nutrition with nucleoside and nucleotide mixture on D-galactosamine-induced liver injury in rats.

Authors:  S Ogoshi; M Iwasa; S Kitagawa; Y Ohmori; S Mizobuchi; Y Iwasa; T Tamiya
Journal:  JPEN J Parenter Enteral Nutr       Date:  1988 Jan-Feb       Impact factor: 4.016

10.  Thioacetamide-induced hepatocarcinoma in rat.

Authors:  A Dasgupta; R Chatterjee; J R Chowdhury
Journal:  Oncology       Date:  1981       Impact factor: 2.935

View more
  6 in total

1.  Hepatic injury due to combined choline-deprivation and thioacetamide administration: an experimental approach to liver diseases.

Authors:  Hussam Al-Humadi; Stamatios Theocharis; Ismene Dontas; Vasileios Stolakis; Apostolos Zarros; Argyro Kyriakaki; Rafal Al-Saigh; Charis Liapi
Journal:  Dig Dis Sci       Date:  2012-07-10       Impact factor: 3.199

2.  Effect of dietary nucleotides on degree of fibrosis and steatosis induced by oral intake of thioacetamide.

Authors:  M I Torres; M I Fernandez; A Gil; A Rios
Journal:  Dig Dis Sci       Date:  1997-06       Impact factor: 3.199

3.  Pharmacokinetics of miriplatin in experimental dog models of hepatic or renal impairment.

Authors:  Atsushi Kitamura; Jin Shimakura; Masashi Yabuki; Hiroyuki Asano; Toshifumi Fukuoka; Minoru Nakano; Setsuko Komuro
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2011-07-08       Impact factor: 2.441

4.  Increased immunoreactivities against endothelin-converting enzyme-1 and monocyte chemotactic protein-1 in hepatic stellate cells of rat fibrous liver induced by thioacetamide.

Authors:  Takahisa Nagata; Hideaki Kudo; Tomoko Nishino; Yoshiaki Doi; Hideaki Itoh; Sunao Fujimoto
Journal:  Med Mol Morphol       Date:  2005-09       Impact factor: 2.309

5.  Hepatotoxic agent thioacetamide induces biochemical and histological alterations in rat small intestine.

Authors:  M A Ortega; M I Torres; M I Fernández; A Rios; A Sánchez-Pozo; A Gil
Journal:  Dig Dis Sci       Date:  1997-08       Impact factor: 3.199

6.  Effect of l-ornithine l-aspartate against thioacetamide-induced hepatic damage in rats.

Authors:  Abul K Najmi; K K Pillai; S N Pal; M Akhtar; M Aqil; M Sharma
Journal:  Indian J Pharmacol       Date:  2010-12       Impact factor: 1.200

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.